We show that inhibition of PD-L1 can suppress platelet activation and improve the formation of arterial thrombosis and stroke by downregulating the Caspase-3/GSDME pathway, suggesting the possibility of targeting PD-L1 as a potential approach for interfering with thrombosis without risk of bleeding. This evidence concerns the gene CD274 and stroke disorder.